ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

House Passes Bill On New Cigarette Labels

September 14, 1984

Simons Named CEO of Prostate Cancer Foundation.

November 17, 2006

NCI’s International Program Growing, With More Agreements, $8 Million In Contracts And Grants

August 8, 1975

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

NCI Plans Contract To Study Cancer Research Manpower Needs; Epidemiologist State Their Case

October 7, 1977

It is The First FDA Withdrawl Of An Accelerated Approval

November 18, 2011